JAGUAR HEALTH, INC. Cost of Revenue
JAGUAR HEALTH, INC. (JAGX) reported Cost of Revenue of $1.03 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2026-08-19
- JAGUAR HEALTH, INC. cost of revenue for the quarter ending 2026-06-30 was $1.03M, a 95.64% increase year-over-year.
- JAGUAR HEALTH, INC. cost of revenue for the quarter ending 2026-03-31 was $1.16M, a 124.85% increase year-over-year.
- JAGUAR HEALTH, INC. cost of revenue for the quarter ending 2025-12-31 was $2.20M, a 294.97% increase year-over-year.
- JAGUAR HEALTH, INC. cost of revenue for the quarter ending 2025-09-30 was $532.00K, a 1.66% decline year-over-year.
- JAGUAR HEALTH, INC. cost of revenue for fiscal 2025 was $3.77M, a 93.04% increase from fiscal 2024.
- JAGUAR HEALTH, INC. cost of revenue for fiscal 2024 was $1.96M, a 4.03% decline from fiscal 2023.
- JAGUAR HEALTH, INC. cost of revenue for fiscal 2023 was $2.04M, a 0.89% increase from fiscal 2022.
- JAGUAR HEALTH, INC. cost of revenue for fiscal 2022 was $2.02M, a 13.46% decline from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 6 month as first filed | Cost of Revenue 9 month | Cost of Revenue 9 month as first filed | Cost of Revenue 12 month | Cost of Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.03M 10-Q · filed 2026-08-19 | $2.19M 10-Q · filed 2026-08-19 | $4.39M derived: sum of 3 quarters · filed 2026-08-19 | $4.92M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2026-03-31 | $1.16M 10-Q · filed 2026-05-20 | $3.36M derived: sum of 2 quarters · filed 2026-05-20 | $3.89M derived: sum of 3 quarters · filed 2026-05-20 | $4.42M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07 | $2.73M derived: sum of 2 quarters · filed 2026-04-07 | $3.26M derived: sum of 3 quarters · filed 2026-08-19 | $3.77M 10-K · filed 2026-04-07 | ||||
| 2025-09-30 | $532.00K 10-Q · filed 2025-11-14 | $1.06M derived: sum of 2 quarters · filed 2026-08-19 | $1.57M 10-Q · filed 2025-11-14 | $2.13M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-06-30 | $527.00K 10-Q · filed 2026-08-19 | $1.04M 10-Q · filed 2026-08-19 | $1.60M derived: sum of 3 quarters · filed 2026-08-19 | $2.14M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-03-31 | $515.00K 10-Q · filed 2026-05-20 | $1.07M derived: sum of 2 quarters · filed 2026-05-20 | $1.61M derived: sum of 3 quarters · filed 2026-05-20 | $2.04M derived: sum of 4 quarters · filed 2026-05-20 | ||||
| 2024-12-31 | $557.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07 | $1.10M derived: sum of 2 quarters · filed 2026-04-07 | $1.52M derived: sum of 3 quarters · filed 2026-04-07 | $1.96M 10-K · filed 2026-04-07 | ||||
| 2024-09-30 | $541.00K 10-Q · filed 2025-11-14 | $968.00K derived: sum of 2 quarters · filed 2025-11-14 | $1.40M 10-Q · filed 2025-11-14 | $2.08M derived: sum of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | $427.00K 10-Q · filed 2025-08-14 | $857.00K 10-Q · filed 2025-08-14 | $1.54M derived: sum of 3 quarters · filed 2025-08-14 | $2.06M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $430.00K 10-Q · filed 2025-05-15 | $1.12M derived: sum of 2 quarters · filed 2025-05-15 | $1.63M derived: sum of 3 quarters · filed 2025-05-15 | $2.12M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $687.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.20M derived: sum of 2 quarters · filed 2025-03-31 | $1.69M derived: sum of 3 quarters · filed 2025-03-31 | $2.04M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $514.00K 10-Q · filed 2024-11-13 | $1.00M derived: sum of 2 quarters · filed 2024-11-13 | $1.35M 10-Q · filed 2024-11-13 | $1.84M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $491.00K 10-Q · filed 2024-08-13 | $836.00K 10-Q · filed 2024-08-13 | $1.33M derived: sum of 3 quarters · filed 2024-08-13 | $1.94M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $345.00K 10-Q · filed 2024-05-14 | $840.00K derived: sum of 2 quarters · filed 2024-05-14 | $1.45M derived: sum of 3 quarters · filed 2024-05-14 | $1.91M derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $495.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $1.11M derived: sum of 2 quarters · filed 2024-04-01 | $1.56M derived: sum of 3 quarters · filed 2024-04-01 | $2.02M 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $613.00K 10-Q · filed 2023-11-14 | $1.07M derived: sum of 2 quarters · filed 2023-11-14 | $1.52M 10-Q · filed 2023-11-14 | $1.99M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $456.00K 10-Q · filed 2023-08-14 | $911.00K 10-Q · filed 2023-08-14 | $1.38M derived: sum of 3 quarters · filed 2023-08-14 | $2.00M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $455.00K 10-Q · filed 2023-05-15 | $924.00K derived: sum of 2 quarters · filed 2023-05-15 | $1.54M derived: sum of 3 quarters · filed 2023-05-15 | $2.21M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $469.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $1.09M derived: sum of 2 quarters · filed 2023-03-24 | $1.75M derived: sum of 3 quarters · filed 2023-03-24 | $2.33M 10-K · filed 2023-03-24 | ||||
| 2021-09-30 | $617.00K 10-Q · filed 2022-11-14 | $1.28M derived: sum of 2 quarters · filed 2022-11-14 | $1.86M 10-Q · filed 2022-11-14 | $2.65M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $664.00K 10-Q · filed 2022-08-22 | $1.25M 10-Q · filed 2022-08-22 | $2.04M derived: sum of 3 quarters · filed 2022-08-22 | $2.82M derived: sum of 4 quarters · filed 2022-08-22 | ||||
| 2021-03-31 | $583.00K 10-Q · filed 2022-05-10 | $1.37M derived: sum of 2 quarters · filed 2022-05-10 | $2.16M derived: sum of 3 quarters · filed 2022-05-10 | $3.19M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | $789.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $1.57M derived: sum of 2 quarters · filed 2022-03-11 | $2.60M derived: sum of 3 quarters · filed 2022-03-11 | $3.28M 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | $784.00K 10-Q · filed 2021-11-17 | $1.81M derived: sum of 2 quarters · filed 2021-11-17 | $2.49M 10-Q · filed 2021-11-17 | $3.23M derived: sum of 4 quarters · filed 2021-11-17 | ||||
| 2020-06-30 | $1.03M 10-Q · filed 2021-08-13 | $1.71M 10-Q · filed 2021-08-13 | $2.45M derived: sum of 3 quarters · filed 2021-08-13 | $3.40M derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | $676.00K 10-Q · filed 2021-05-17 | $1.42M derived: sum of 2 quarters · filed 2021-05-17 | $2.37M derived: sum of 3 quarters · filed 2021-05-17 | $3.63M derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | $743.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $1.69M derived: sum of 2 quarters · filed 2021-03-31 | $2.95M derived: sum of 3 quarters · filed 2021-03-31 | $3.82M 10-K · filed 2021-03-31 | $3.82M 10-K · filed 2020-04-03 | |||
| 2019-09-30 | $948.00K 10-Q · filed 2020-11-16 | $947.50K 10-Q · filed 2019-11-14 | $2.21M derived: sum of 2 quarters · filed 2020-11-16 | $3.07M 10-Q · filed 2020-11-16 | $3.07M 10-Q · filed 2019-11-14 | $4.03M derived: sum of 4 quarters · filed 2020-11-16 | ||
| 2019-06-30 | $1.26M 10-Q · filed 2020-08-13 | $1.26M 10-Q · filed 2019-08-14 | $2.13M 10-Q · filed 2020-08-13 | $2.13M 10-Q · filed 2019-08-14 | $3.08M derived: sum of 3 quarters · filed 2020-08-13 | $3.82M derived: sum of 4 quarters · filed 2020-08-13 | ||
| 2019-03-31 | $865.00K 10-Q · filed 2020-05-15 | $864.94K 10-Q · filed 2019-05-21 | $1.82M derived: sum of 2 quarters · filed 2020-05-15 | $2.56M derived: sum of 3 quarters · filed 2020-05-15 | $3.17M derived: sum of 4 quarters · filed 2020-05-15 | |||
| 2018-12-31 | $956.83K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03 | $1.69M derived: sum of 2 quarters · filed 2020-04-03 | $2.30M derived: sum of 3 quarters · filed 2020-04-03 | $2.77M 10-K · filed 2020-04-03 | ||||
| 2018-09-30 | $736.73K 10-Q · filed 2019-11-14 | $1.34M derived: sum of 2 quarters · filed 2019-11-14 | $1.81M 10-Q · filed 2019-11-14 | $2.44M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | $608.02K 10-Q · filed 2019-08-14 | $1.07M 10-Q · filed 2019-08-14 | $1.71M derived: sum of 3 quarters · filed 2019-08-14 | $1.91M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | $464.16K 10-Q · filed 2019-05-21 | $1.10M derived: sum of 2 quarters · filed 2019-05-21 | $1.30M derived: sum of 3 quarters · filed 2019-05-21 | $1.33M derived: sum of 4 quarters · filed 2019-05-21 | ||||
| 2017-12-31 | $633.27K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-10 | $839.50K derived: sum of 2 quarters · filed 2019-04-10 | $864.26K derived: sum of 3 quarters · filed 2019-04-10 | $880.40K 10-K · filed 2019-04-10 | ||||
| 2017-09-30 | $206.23K 10-Q · filed 2018-11-19 | $230.99K derived: sum of 2 quarters · filed 2018-11-19 | $247.13K 10-Q · filed 2018-11-19 | $262.23K derived: sum of 4 quarters · filed 2018-11-19 | ||||
| 2017-06-30 | $24.76K 10-Q · filed 2018-08-13 | $40.91K 10-Q · filed 2018-08-13 | $56.01K derived: sum of 3 quarters · filed 2018-08-13 | $65.86K derived: sum of 4 quarters · filed 2018-08-13 | ||||
| 2017-03-31 | $16.14K 10-Q · filed 2018-05-15 | $31.24K derived: sum of 2 quarters · filed 2018-05-15 | $41.10K derived: sum of 3 quarters · filed 2018-05-15 | $49.74K derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | $15.10K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-09 | $24.96K derived: sum of 2 quarters · filed 2018-04-09 | $33.60K derived: sum of 3 quarters · filed 2018-04-09 | $51.97K 10-K · filed 2018-04-09 | ||||
| 2016-09-30 | $9.86K 10-Q · filed 2017-11-20 | $18.50K derived: sum of 2 quarters · filed 2017-11-20 | $36.87K 10-Q · filed 2017-11-20 | $72.44K derived: sum of 4 quarters · filed 2017-11-20 | ||||
| 2016-06-30 | $8.64K 10-Q · filed 2017-08-09 | $27.01K 10-Q · filed 2017-08-09 | $62.58K derived: sum of 3 quarters · filed 2017-08-09 | $99.21K derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2016-03-31 | $18.37K 10-Q/A · filed 2017-06-23 | $53.94K derived: sum of 2 quarters · filed 2017-06-23 | $90.57K derived: sum of 3 quarters · filed 2017-06-23 | $107.53K derived: sum of 4 quarters · filed 2017-06-23 | ||||
| 2015-12-31 | $35.57K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-15 | $72.20K derived: sum of 2 quarters · filed 2017-02-15 | $89.16K derived: sum of 3 quarters · filed 2017-02-15 | $123.46K 10-K · filed 2017-02-15 | ||||
| 2015-09-30 | $36.63K 10-Q · filed 2016-11-14 | $53.59K derived: sum of 2 quarters · filed 2016-11-14 | $87.89K 10-Q · filed 2016-11-14 | |||||
| 2015-06-30 | $16.96K 10-Q · filed 2016-08-15 | $51.26K 10-Q · filed 2016-08-15 | ||||||
| 2015-03-31 | $34.30K 10-Q · filed 2016-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |